Biomimetic scaffolds mimic human subretinal debris for preclinical testing of prosthetic vision

For millions of people, the world is slowly fading into darkness due to a condition called age-related macular degeneration. In its most severe form, the light-sensitive cells at the very back of the eye, known as photoreceptors, simply die away. While the cells that receive signals from these photoreceptors often survive, the connection is broken, leaving the brain without visual input. To restore sight, scientists are developing tiny electronic implants that sit beneath the retina. These devices act as artificial eyes, converting light into electrical pulses that stimulate the surviving nerve cells, hoping to trick the brain into seeing again. However, there is a significant hurdle in testing these devices. In human patients, a layer of cellular debris and scar tissue often remains between the dead photoreceptors and the living nerves. This layer acts like a cushion, pushing the implant away from the target cells. In the animals used for testing, such as rats, this cushion does not exist; the implant sits directly against the nerves. This difference makes it difficult to know if a new implant will work well in a human eye, where the distance is greater and the electrical signals must travel through that extra layer of material.

Researchers at Stanford University and the University of Central Florida have developed a solution to this testing problem: a microscopic, three-dimensional scaffold that mimics the human condition. They created a tiny, porous mesh that can be printed directly onto the surface of the implant. This mesh is designed to hold the living nerve cells at a specific distance from the device, just as the debris layer does in a human eye, while still allowing light to pass through to the implant and electricity to flow to the nerves. The team tested these scaffolds in rats, adjusting the size of the holes in the mesh to find the perfect balance. They discovered that a gap of 3 micrometers was ideal. This size was small enough to stop the nerve cells from migrating down into the implant, which would ruin the test, but large enough to let the necessary biological fluids and electrical currents move freely.

When these scaffolds were implanted, they created a stable, controlled space between the device and the retina. Over time, the empty space inside the scaffold naturally filled with biological material from the eye, becoming dense enough to match the electrical properties of the tissue found in human patients. This transition was crucial. Initially, the space was filled with fluid, which conducts electricity too easily and blurs the visual signal. As the space filled with tissue-like material, the clarity of the electrical signal improved, and the rats' ability to see fine patterns became sharper. The researchers found that the electrical thresholds required to stimulate the nerves changed in the exact same way as they do when the distance increases in a natural human eye. This means the scaffold successfully recreated the challenging environment of a diseased human eye within a rat model.

The study also addressed a specific problem with newer, more advanced implants that use tiny pillars to reach deeper into the retina. Without a barrier, the nerve cells in rats tend to grow down around these pillars, moving closer to the device than intended. This migration changes how the electricity reaches the cells, making the test results unreliable. The new scaffolds acted as a fence, keeping the nerve cells at the top of the pillars where the researchers wanted them to be. By preventing this migration, the team ensured that the distance between the electrode and the target cell remained constant and predictable. This allowed them to measure exactly how the size of the implant's pixels and the distance to the nerves affected the quality of vision.

The results suggest that this biomimetic scaffold provides a much more accurate way to test the next generation of vision-restoring devices. By reproducing the physical separation and electrical resistance found in human patients, the model bridges the gap between animal studies and clinical reality. The researchers confirmed that the scaffold did not block the light needed to power the implant, nor did it interfere with the flow of electricity. Instead, it created a realistic environment where the performance of the implant could be judged fairly. This work establishes a new standard for preclinical testing, ensuring that the devices developed in the lab are truly ready for the complex, debris-filled environment of the human eye.